Meeting
2020 Gastrointestinal Cancers Symposium
Provider perspective: The clinical value of a novel digital medicine program in gastrointestinal oncology.
Authors
Edward Greeno
University of Minnesota, Minneapolis, MN
Edward Greeno , Paul Morales , Daniel Beiswenger , Xue Wang , Ellen Travis , R. Scooter Plowman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Anal and Colorectal Cancer
Track
Colorectal Cancer,Anal Cancer
Sub Track
Quality of Care/Quality Improvement
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 76)
Abstract #
76
Poster Bd #
D6
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
REPROGRAM-02: A phase II-III study evaluating an induction treatment with regorafenib and metronomic chemotherapy before the second line chemotherapy in metastatic colorectal cancer.
First Author: Angelique Vienot
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Real-world assessment of capecitabine and oxaliplatin (CAPOX) tolerability in patients with localized colorectal cancer undergoing curative-intent therapy: A comprehensive single institution analysis.
First Author: Veronica Mears
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Patient-reported outcomes in patients with gastrointestinal cancer on oral chemotherapy.
First Author: Kevin Juan Zhang
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Clonal hematopoiesis of indeterminate potential (CHIP), treatment outcomes and adverse events in gastrointestinal cancers: A pooled analysis of clinical trial and real-world data.
First Author: Tharani Krishnan